We hypothesized that continuous positive airway pressure (CPAP) therapy could improve sleep-induced left ventricular (LV) dysfunction in patients with obstructive sleep apnoea syndrome (OSA). The aim of this study was to investigate the effects of CPAP therapy on LV systolic dysfunction during overnight sleep in patients with OSA using twodimensional speckle-tracking echocardiography (2DSTE).
Introduction
In patients with obstructive sleep apnoea syndrome (OSA), repetitive hypoxia due to sleep-induced apnoea and/or hypopnoea adversely affects the interaction between myocardial oxygen demand and supply, resulting in the development of subclinical left ventricular (LV) systolic dysfunction. 1 Previous echocardiographic studies using tissue-Doppler imaging (TDI) have demonstrated that overnight sleeping in OSA patients is associated with the development of subclinical LV systolic dysfunction and exaggerated diastolic dysfunction, as assessed by mitral annular velocity. 2 However, due to the angle dependency of TDI, the adverse effects of overnight sleeping on LV regional and global mechanics, such as strain, have not been clarified. In patients with heart failure and OSA, continuous positive airway pressure (CPAP) therapy has been shown to improve LV systolic dysfunction, principally due to a reduction in LV afterload. 3 However, it has not been determined whether CPAP therapy has a beneficial impact on LV systolic function during overnight sleeping.
Two-dimensional speckle-tracking echocardiography (2DSTE) provides non-invasive angle-independent measurements of global and regional LV strain and has the potential for quantitative assessment of LV mechanics. 4 -6 We hypothesized that overnight sleeping in patients with OSA results in LV longitudinal dysfunction and that CPAP therapy might correct these sleep-induced abnormalities. Thus, the aims of this study were (i) to investigate the acute adverse impact of overnight sleeping on global and regional LV strain in patients with OSA using 2DSTE and (ii) to evaluate the effects of CPAP therapy on LV global and regional systolic function during overnight sleeping.
Methods

Study protocol
Thirty-six consecutive patients with newly diagnosed OSA were recruited in this study ( Figure 1 ). Exclusion criteria included (i) central sleep apnoea, (ii) history of coronary artery disease or electrocardiographic changes suggestive of myocardial infarction, (iii) presence of LV systolic dysfunction (LV ejection fraction, LVEF , 50%), (iv) a history of congestive heart failure, (v) atrial fibrillation, (vi) moderate to severe valvular heart disease, (vii) cardiomyopathy, (viii) history of chronic obstructive pulmonary disease or asthma, and (ix) previous diagnosis of OSA and/or previous use of CPAP therapy. All patients complained of daytime sleepiness and/or loud snoring. The Ethics Committee approved the protocol, and all subjects gave written informed consent prior to the study participation. All patients underwent overnight polysomnography (PSG) to establish the presence and severity of OSA. In each patient, a complete transthoracic echocardiogram was performed before sleep and immediately after awakening the following morning. Four patients with OSA had poor echocardiographic windows due to obesity and were excluded from the analysis. Thus, the final group consisted of 32 patients with OSA. A total of 20 patients diagnosed with moderate or severe OSA (apnoea -hypopnoea index; AHI ! 20) then received chronic nasal CPAP therapy. However, six patients withdrew from CPAP therapy due to difficulties wearing the CPAP mask continuously. Accordingly, 14 patients underwent a repeat full-night CPAP titration study and the same echocardiographic examinations 3 months after initiation of CPAP therapy.
Sleep study
Overnight PSG was performed in the sleep laboratory using standard recording techniques (Sleep watcher E series, Compumedics, Abbotsville, Australia) and Profusion PSG. Surface electrodes were applied for electroencephalogram, chin electromyogram, electrocardiogram, and electrooculography recordings. Airflow was monitored using an air pressure sensor placed at the nose with thermistor placed at the nose and mouth, whereas arterial oxygen saturation (SaO 2 ) was recorded continuously using a pulse oximeter. Arousals were scored according to the accepted definitions. 7 Sleep stages were scored according to the standard criteria of the American Academy of Sleep Medicine. 8 Apnoeas were defined as complete cessation of inspiratory airflow for at least 10 s. Hypopnoea was defined as a significant reduction (.50%) in respiratory signals for at least 10 s associated with an arousal or reduction in SaO 2 of more than 3% of baseline value. The AHI was defined as the number of apnoea and/ or hypopnoea events per hour of sleep. Patients with AHI of five times per hour or more were considered to have OSA.
Conventional echocardiographic measurements
Echocardiographic examination was performed using a commercially available ultrasound machine (Vivid i, GE Healthcare, Haifa, Israel) and 3S-RS (3.5 MHz) transducer. LV short-axis views were recorded at basal, middle, and apical levels (81 + 4 frames/s, range: 72 -88 frames/s) in the second harmonic mode. In addition, apical fourchamber, two-chamber, and long-axis views were acquired (81 + 4 frames/s, range: 67 -89 frames/s). In each plane, three consecutive cardiac cycles were acquired during a breath hold and digitally stored on a hard disk for offline analysis. LV end-diastolic and endsystolic volumes and LVEF were calculated using the modified Simpson's method from apical four-chamber and two-chamber views. To determine the timing of cardiac phases, LV inflow and outflow velocities were recorded using pulsed-wave Doppler echocardiography. End-systole was defined at the point of aortic valve closure. An experienced cardiologist who was unaware of PSG results performed all examinations.
Two-dimensional speckle-tracking echocardiography analysis
We measured three principal LV strain using commercially available 2D strain software (EchoPAC PC, version 6.0, GE Healthcare, Horten, Norway). From the apical and short-axis datasets, one cardiac cycle was selected for subsequent analysis. 2D strain was measured as previously described. 9 Briefly, the endocardial border at end-systolic frame was manually traced. A region of interest was then drawn to include the entire myocardium. The software divided the LV into six segments and performed speckle-tracking analysis throughout one cardiac cycle. Finally, the software automatically created the timedomain LV strain curves in six segments, from which end-systolic strain was calculated. Global longitudinal strain was defined as the 2DSTE in OSA averaged longitudinal strains at end-systole in 18 segments from three apical views. Global radial and circumferential strains were defined as averaged radial and circumferential strain at end-systole in 18 segments from three levels of short-axis views.
We also evaluated longitudinal post-systolic shortening. From timedomain longitudinal strain waveforms throughout the cardiac cycle, we measured strain at end-systole (LSes) as well as post-systolic peak longitudinal strain (LSpss). The post-systolic index (PSI) was calculated as [(LSpss -LSes)/LSes)] Â 100 (%) in each segment, and these values were averaged in 18 segments. Whenever PSS was not present, PSI value of 0 was given.
Inter-and intra-observer variability
Intra-observer variability was determined by having one observer repeat the measurement of global longitudinal, radial, and circumferential strain in 10 randomly selected patients 1 month after the first measurement. Inter-observer variability was determined by having a second observer measure these variables in the same datasets. Intraand inter-observer variabilities were then calculated as the absolute difference between the corresponding two measurements as a percent of their mean. Intra-and inter-observer reproducibility were evaluated by means of the intra-class correlation coefficient (ICC).
Statistical analysis
Data were expressed as mean values + SD. Frequencies were expressed as percentages. All statistical analysis was carried out using commercially available statistical software (Statview, version 5.0, SAS Institute Inc., Cary, NC, USA). Inter-group differences in continuous variables were compared using paired t-tests. Linear regression analysis was used to investigate the relationship between two parameters. Univariate and multivariate liner regression analysis was performed to determine independent predictors between absolute reduction of global longitudinal strain and clinical and haemodynamic parameters including age, gender, body weight, height, history of diabetes, hyperlipidaemia, smoking, systolic blood pressure, heart rate, LV mass index, echocardiographic diastolic parameters, and minimal oxygen saturation. A P-value of ,0.05 was considered to be significant.
Results
Baseline findings
The clinical characteristics, standard echocardiographic, and PSG findings are shown in Table 1 .
Acute overnight change of left ventricular function
Although heart rate was significantly decreased after sleep, no significant differences in systolic or diastolic blood pressure or LVEF were noted before or after overnight sleeping ( Table 2) . Also, no significant changes in global radial and circumferential strain during overnight sleeping were noted. However, global and segmental longitudinal strains were significantly reduced after overnight sleeping. The longitudinal post-systolic shortening index was also significantly increased after overnight sleeping (2.9 + 1.9 vs. 5.4 + 3.5%, P , 0.001). Although absolute decrease in longitudinal, radial, and circumferential strain tended to be larger in patients with moderate or severe OSA (AHI ! 20/h) compared with those with mild OSA (5 , AHI , 20/h), no statistically significant differences between these groups were noted. No significant correlation was noted between absolute reduction of global longitudinal strain and AHI (r ¼ 0.32, P ¼ ns). However, a weak but significant correlation was found between absolute reduction of global longitudinal strain and minimal oxygen saturation (r ¼ 0.40, P , 0.05). When considering absolute reduction of longitudinal strain in the six apical segments, the earliermentioned correlations were improved showing statistical significance (AHI: r ¼ 0.41, P , 0.05, minimal oxygen saturation: r ¼ 0.49, P , 0.005).
Univariate liner regression analysis revealed that absolute reduction of longitudinal strain is significantly correlated with minimal oxygen saturation. Using multivariate regression analysis, minimal oxygen saturation was found to be the only independent predictor of the absolute reduction of global longitudinal strain ( Table 3) .
Effect of continuous positive airway pressure therapy on left ventricular function
A subset of 14 patients who successfully underwent full-night nasal CPAP therapy for minimum of 3 months participated in a repeat Data are presented as mean + SD or numbers (%).
sleep and echocardiographic study. In this subset of patients, AHI and minimal O 2 saturation were significantly improved after CPAP therapy (AHI; 56 + 19 to 5 + 8/h, P , 0.001, minimal O 2 saturation; 77 + 8% to 91 + 6%, P , 0.001). Prior to the initiation of CPAP therapy, global longitudinal strain was significantly decreased during overnight sleeping (220.9 + 2.3 to 218.9 + 2.2, P , 0.005). After the CPAP therapy, significant reduction in longitudinal strain during overnight sleep was no longer seen (221.3 + 1.9 to 220.7 + 1.6, P ¼ ns). Furthermore, a significant increase in longitudinal PSI after overnight sleep was also no longer seen after 3 months of CPAP therapy ( Figure 2) . A representative case is shown in Figure 3 .
Observer variabilities
Intra-observer variability of global longitudinal, radial, and circumferential strain was 3.6, 12.1, and 9.2%, respectively. Corresponding ICC was 0.95, 0.92, and 0.90, respectively. Inter-observer variability of the corresponding values was 5.7, 15.0, and 10.6%, respectively. Corresponding ICC was 0.88, 0.86, and 0.61, respectively.
Discussion
The development of 2DSTE enables accurate and reliable measurements of both global and regional myocardial strain without confounding effects of angle dependency. 12 Several 2DSTE studies have been shown that LV strain was reduced in patients with asymptomatic hypertrophic cardiomyopathy with normal LVEF. 5, 13 To the best of our knowledge, this is the first study to demonstrate that overnight sleeping in patients with OSA result in a reduction of longitudinal strain and that this corrected after effective CPAP therapy for 3 months.
Acute overnight change of subclinical left ventricular systolic function
Sleeping is usually accompanied by reductions in central sympathetic tone, heart rate, blood pressure, and cardiac output.
14 Changes in preload and afterload are important determinants for myocardial performance. 5 Although a reduction in preload during overnight sleeping might be expected to affect the change in LV strain seen in this study, this possibility seems to be low based on the fact that no significant changes in LV volumes or in LVEF were noted during overnight sleep. On the other hand, OSA patients experience repeat increases in LV afterload during sleeping, due to (i) the exaggeration of negative intrathoracic pressure and (ii) to intermittent hypoxia and arousal. Acute repeated increase with OSA in afterload can result in a reduction of LV systolic function. 15 However, blood pressure in OSA patients on the morning following sleep was found to be comparable to that measured prior to sleep. Multivariate analysis revealed that heart rate and blood pressure were not independent predictors responsible for the reduction of longitudinal strain. Thus, an increase in afterload caused by elevated blood pressure was probably not the main cause of LV systolic longitudinal dysfunction seen in this study. In normal human subjects, short-term hypoxic exposure has been shown to increase heart rate, LVEF, and cardiac output. 16 In contrast, Kaneko et al. 17 reported that intermittent hypoxia during obstructive apnoea may directly impair cardiac contractility. The myocardial oxygen supply is diminished by hypoxia, which may therefore be a cause of myocardial ischaemia in OSA patients. 1 Because subendocardial myocardial fibres, which course longitudinally, are especially vulnerable to myocardial ischaemia, longitudinal dysfunction could develop earlier than radial and circumferential dysfunction, a prediction that is in agreement with our results. 9, 18, 19 A significant increase in post-systolic shortening after sleep also supported the development of sleep-induced myocardial ischaemia in patients with OSA. Furthermore, a weak but significant correlation between absolute reduction of global longitudinal strain and severity of OSA (minimum oxygen saturation) was noted. The reduction of longitudinal strain was more prominent in the apex than in the middle and basal levels of the LV. This preferential reduction of longitudinal strain in the apex is understandable because the apex, being located most peripherally in the coronary circulation, is most vulnerable to global hypoxia. Thus, intermittent hypoxia due to repetitive obstructive apnoea could produce subclinical LV systolic dysfunction during overnight sleep in OSA patients.
Effect of continuous positive airway pressure therapy on subclinical left ventricular systolic function CPAP therapy is the standard treatment for patients with OSA. CPAP therapy reduces the frequency of obstructive events and arousals and improves arterial oxygenation during sleeping, resulting in diminished sympathetic nervous activation, reduction in LV afterload, and elimination of exaggerated negative intrathoracic pressure. 17 However, controversy exists regarding the beneficial impact of CPAP on LV systolic function. Bayram et al. 20 reported that peak systolic mitral annular velocity assessed by TDI did not differ between patients with OSA patients and preserved LVEF and control subjects. These investigators also showed that peak Figure 2 Change in global longitudinal strain and post-systolic shortening index during overnight sleeping in a subset of patients who had chronic CPAP therapy. Left panels show each data point and mean + SD before the CPAP therapy, and right panels show these variables at 3 months after the therapy.
systolic annular velocity did not change after 6 months of effective CPAP therapy. In contrast, Shivalkar et al. 11 reported that systolic annular velocity was significantly increased after 6 months of CPAP therapy. The angle dependency of TDI-derived velocity data resulting in large test-retest variabilities, probably causing these discrepant results. In contrast, 2DSTE is angle independent and thus exhibits lower measurement variability. The finding that longitudinal strain reduction during overnight sleeping disappeared after 3 months of CPAP therapy supports the idea that chronic CPAP therapy has a beneficial impact on LV systolic function.
Limitations
Several limitations of this study should be addressed. The accuracy of 2DSTE depends greatly on the image quality. In our study, 2DSTE was not feasible in four of 36 OSA patients because of poor image quality. We cannot exclude the possibility that some OSA patients had coronary artery disease. However, performing invasive coronary angiography in asymptomatic OSA patients is not justified.
Conclusions
Obstructive apnoea and hypopnoea during overnight sleeping induce acute subclinical longitudinal LV dysfunction; this observation suggests that patients with OSA may develop subclinical myocardial ischaemia. CPAP therapy improves not only the severity of OSA but also overnight sleep-induced subclinical LV dysfunction, which can be assessed by 2DSTE.
